Abstract
The development of bio-based nanostructures as nanocarriers of bioactive compounds to specific body sites has been presented as a hot topic in food, pharmaceutical and nanotechnology fields. Food and pharmaceutical industries seek to explore the huge potential of these nanostructures, once they can be entirely composed of biocompatible and non-toxic materials. At the same time, they allow the incorporation of lipophilic and hydrophilic bioactive compounds protecting them against degradation, maintaining its active and functional performance. Nevertheless, the physicochemical properties of such structures (e.g., size and charge) could change significantly their behavior in the gastrointestinal (GI) tract. The main challenges in the development of these nanostructures are the proper characterization and understanding of the processes occurring at their surface, when in contact with living systems. This is crucial to understand their delivery and absorption behavior as well as to recognize potential toxicological effects. This review will provide an insight into the recent innovations and challenges in the field of delivery via GI tract using bio-based nanostructures. Also, an overview of the approaches followed to ensure an effective deliver (e.g., avoiding physiological barriers) and to enhance stability and absorptive intestinal uptake of bioactive compounds will be provided. Information about nanostructures’ potential toxicity and a concise description of the in vitro and in vivo toxicity studies will also be given.
Similar content being viewed by others
References
Acosta E (2009) Bioavailability of nanoparticles in nutrient and nutraceutical delivery. Curr Opin Colloid Interface Sci 14:3–15
Agrawal GK, Timperio AM, Zolla L, Bansal V, Shukla R, Rakwal R (2013) Biomarker discovery and applications for foods and beverages: proteomics to nanoproteomics. J Proteomics 93:74–92
Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML (2009) Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev 61:457–466
Akbulut O, Mace CR, Martinez RV, Kumar AA, Nie Z, Patton MR, Whitesides GM (2012) Separation of nanoparticles in aqueous multiphase systems through centrifugation. Nano Lett 12:4060–4064
Alemdaroglu FE, Alemdaroglu NC, Langguth P, Herrmann A (2008) Cellular uptake of DNA block copolymer micelles with different shapes. Macromol Rapid Commun 29:326–329
Arora S, Rajwade JM, Paknikar KM (2012) Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharmacol 258:151–165
Atal N, Bedi K (2010) Bioenhancers: revolutionary concept to market. J Ayurveda Integr Med 1:96–99
Aungst BJ (2012) Absorption enhancers: applications and advances. AAPS J 14:10–18
Azevedo MA, Bourbon AI, Vicente AA, Cerqueira MA (2014) Alginate/chitosan nanoparticles for encapsulation and controlled release of vitamin B2. Int J Biol Macromol 71:141–146
Bergin IL, Witzmann FA (2013) Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol 3:163–210
Berton-Carabin CC, Coupland JN, Elias RJ (2013) Effect of the lipophilicity of model ingredients on their location and reactivity in emulsions and solid lipid nanoparticles. Colloids Surf Physicochem Eng Asp 431:9–17
Blasco C, Picó Y (2011) Determining nanomaterials in food. TrAC-Trend Anal Chem 30:84–99
Bouwmeester H, Dekkers S, Noordam MY, Hagens WI, Bulder AS, de Heer C, ten Voorde SECG, Wijnhoven SWP, Marvin HJP, Sips AJAM (2009) Review of health safety aspects of nanotechnologies in food production. Regul Toxicol Pharmacol 53:52–62
Buehler MJ, Cranford S (2010) Materiomics: biological protein materials, from nano to macro. Nanotechnol Sci Appl 3:127–147
Cerqueira M, Pinheiro AC, Silva HD, Ramos PE, Azevedo MA, Flores-López ML, Rivera MC, Bourbon AI, Ramos ÓL, Vicente AA (2014) Design of bio-nanosystems for oral delivery of functional compounds. Food Eng Rev 6:1–19
Chalasani KB, Russell-Jones GJ, Jain AK, Diwan PV, Jain SK (2007) Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Release 122:141–150
Chang C (2010) The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 34:J234–J246
Chen L, Subirade M (2006) Alginate–whey protein granular microspheres as oral delivery vehicles for bioactive compounds. Biomaterials 27:4646–4654
Chen L, Remondetto GE, Subirade M (2006) Food protein-based materials as nutraceutical delivery systems. Trends Food Sci Technol 17:272–283
Chen M-C, Mi F-L, Liao Z-X, Hsiao C-W, Sonaje K, Chung M-F, Hsu L-W, Sung H-W (2013) Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Adv Drug Del Rev 65:865–879
Chithrani BD, Ghazani AA, Chan WCW (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–668
Couvreur P, Kante B, Roland M, Guiot P, Bauduin P, Speiser P (1979) Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J Pharm Pharmacol 31:331–332
Cui J, van Koeverden MP, Müllner M, Kempe K, Caruso F (2014) Emerging methods for the fabrication of polymer capsules. Adv Colloid Interface Sci 207:14–31
Dandekar PP, Jain R, Patil S, Dhumal R, Tiwari D, Sharma S, Vanage G, Patravale V (2010) Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation. J Pharm Sci 99:4992–5010
Das RK, Kasoju N, Bora U (2010) Encapsulation of curcumin in alginate–chitosan–pluronic composite nanoparticles for delivery to cancer cells. Nanomed Nanotechnol Biol Med 6:153–160
David-Birman T, Mackie A, Lesmes U (2013) Impact of dietary fibers on the properties and proteolytic digestibility of lactoferrin nano-particles. Food Hydrocoll 31:33–41
De Lima R, Feitosa L, Pereira AdES, De Moura MR, Aouada FA, Mattoso LHC, Fraceto LF (2010) Evaluation of the genotoxicity of chitosan nanoparticles for use in food packaging films. J Food Sci 75:N89–N96
del Mercato LL, Rivera-Gil P, Abbasi AZ, Ochs M, Ganas C, Zins I, Sonnichsen C, Parak WJ (2010) LbL multilayer capsules: recent progress and future outlook for their use in life sciences. Nanoscale 2:458–467
Delcea M, Möhwald H, Skirtach AG (2011) Stimuli-responsive LbL capsules and nanoshells for drug delivery. Adv Drug Del Rev 63:730–747
Dell’Orco D, Lundqvist M, Cedervall T, Linse S (2012) Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening. Nanomed Nanotechnol Biol Med 8:1271–1281
des Rieux A, Fievez V, Garinot M, Schneider Y-J, Préat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1–27
Desai M, Labhasetwar V, Amidon G, Levy R (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13:1838–1845
Díaz B, Sánchez-Espinel C, Arruebo M, Faro J, de Miguel E, Magadán S, Yagüe C, Fernández-Pacheco R, Ibarra MR, Santamaría J, González-Fernández Á (2008) Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small 4:2025–2034
Dickinson E (2009) Hydrocolloids as emulsifiers and emulsion stabilizers. Food Hydrocoll 23:1473–1482
Dobrovolskaia MA, McNeil SE (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release 172:456–466
Doh H-J, Jung Y, Balakrishnan P, Cho H-J, Kim D-D (2013) A novel lipid nanoemulsion system for improved permeation of granisetron. Colloids Surf B Biointerfaces 101:475–480
Donato-Capel L, Garcia-Rodenas CL, Pouteau E, Lehmann U, Srichuwong S, Erkner A, Kolodziejczyk E, Hughes E, Wooster TJ, Sagalowicz L (2014) Technological means to modulate food digestion and physiological response. In: Boland M, Golding M, Singh H (eds) Food structures, digestion and health, 1st edn. Academic Press, San Diego
Drusch S (2007) Sugar beet pectin: a novel emulsifying wall component for microencapsulation of lipophilic food ingredients by spray-drying. Food Hydrocoll 21:1223–1228
Dufort S, Sancey L, Coll J-L (2012) Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution. Adv Drug Del Rev 64:179–189
EC (2008) Commission Recommendation of 07/02/2008 on a Code of Conduct for Responsible Nanosciences and Nanotechnologies Research 1-10
EC (2011) Commission recommendation of 18 October 2011 on the definition of nanomaterial. Off J Eur Union 275:38–40
EC (2013) Commission delegated regulation (EU) no 1363/2013 of 12 December 2013 amending regulation (EU) no 1169/2011 of the European Parliament and of the Council on the provision of food information to consumers as regards the definition of ‘engineered nanomaterials’. Off J Eur Union 343:26–28
EFSA (2009) Scientific Opinion of the Scientific Committee. The potential risks arising from nanoscience and nanotechnologies on food and feed safety. EFSA J 958:1–39
EFSA (2011) Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA J 9:2140
Elsabahy M, Wooley KL (2013) Cytokines as biomarkers of nanoparticle immunotoxicity. Chem Soc Rev 42:5552
Elzoghby AO, Samy WM, Elgindy NA (2012) Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release 161:38–49
Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Del Rev 64:557–570
FAO/WHO (2010) FAO/WHO expert meeting on the application of nanotechnologies in the food and agriculture sectors: potential food safety implications: Meeting Report, Rome
FDA (2014) Considering whether an FDA-regulated product involves the application of nanotechnology. http://www.fda.gov/regulatoryinformation/guidances/ucm257698.htm. Accessed 08 May 2014
Feng C, Wang Z, Jiang C, Kong M, Zhou X, Li Y, Cheng X, Chen X (2013) Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation. Int J Pharm 457:158–167
Feng C, Sun G, Wang Z, Cheng X, Park H, Cha D, Kong M, Chen X (2014) Transport mechanism of doxorubicin loaded chitosan based nanogels across intestinal epithelium. Eur J Pharm Biopharm 87:197–207
Fischer HC, Chan WCW (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565–571
Fischer KE, Jayagopal A, Nagaraj G, Daniels RH, Li EM, Silvestrini MT, Desai TA (2011) Nanoengineered surfaces enhance drug loading and adhesion. Nano Lett 11:1076–1081
FSA (2006) Draft Food Standards Agency regulatory review on nanotechnology in food: issue for comment. http://www.food.gov.uk/multimedia/pdfs/int060401a.pdf. Accessed 08-05-2014
Genot AJ, Fujii T, Rondelez Y (2013) In vitro regulatory models for systems biology. Biotechnol Adv 31:789–796
Giese C, Marx U (2014) Human immunity in vitro—solving immunogenicity and more. Adv Drug Del Rev 69–70:103–122
Grassi M, Grassi G, Lapasin R, Colombo I (2007) Understanding drug release and absorption mechanisms: a physical and mathematical approach. CRC Press, Boca Raton
Guri A, Gülseren I, Corredig M (2013) Utilization of solid lipid nanoparticles for enhanced delivery of curcumin in cocultures of HT29-MTX and Caco-2 cells. Food Funct 4:1410–1419
Guzey D, McClements DJ (2006) Characterization of β-lactoglobulin–chitosan interactions in aqueous solutions: a calorimetry, light scattering, electrophoretic mobility and solubility study. Food Hydrocoll 20:124–131
Hafner A, Lovrić J, Voinovich D, Filipović-Grčić J (2009) Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm 381:205–213
He B, Lin P, Jia Z, Du W, Qu W, Yuan L, Dai W, Zhang H, Wang X, Wang J (2013) The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells. Biomaterials 34:6082–6098
Hennink WE, van Nostrum CF (2012) Novel crosslinking methods to design hydrogels. Adv Drug Del Rev 64(Supplement):223–236
Hu L, Mao Z, Gao C (2009) Colloidal particles for cellular uptake and delivery. J Mater Chem 19:3108–3115
Hunter AC, Elsom J, Wibroe PP, Moghimi SM (2012) Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomed Nanotechnol Biol Med 8:S5–S20
ISO (2008) Nanotechnologies—terminology and definitions for nano-objects: nanoparticle, nanofibre and nanoplate ISO/TS 27687:2008
Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, Huang Y (2012) Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 33:1573–1582
Joshi G, Kumar A, Sawant K (2014) Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery. Eur J Pharm Sci 60:80–89
Joye IJ, McClements DJ (2014) Biopolymer-based nanoparticles and microparticles: fabrication, characterization, and application. Curr Opin Colloid Interface Sci 19(5):417–427
Joye IJ, Davidov-Pardo G, McClements DJ (2014) Nanotechnology for increased micronutrient bioavailability. Trends Food Sci Technol 40(2):168–182
Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T (2000) Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm 50:147–160
Kabanov AV, Vinogradov SV (2009) Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed Engl 48(30):5418–5429
Karakoti AS, Hench LL, Seal S (2006) The potential toxicity of nanomaterials - the role of surfaces. JOM 58:77–82
Kesarwani K, Gupta R (2013) Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed 3:253–266
Kettiger H, Schipanski A, Wick P, Huwyler J (2013) Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int J Nanomed 8:3255
Khalid N, Kobayashi I, Neves MA, Uemura K, Nakajima M (2013) Preparation and characterization of water-in-oil emulsions loaded with high concentration of l-ascorbic acid. LWT Food Sci Technol 51:448–454
Kim J-E, Yoon I-S, Cho H-J, Kim D-H, Choi Y-H, Kim D-D (2014) Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicity. Int J Pharm 464(1–2):117–126
Kong F, Singh RP (2010) A human gastric simulator (HGS) to study food digestion in human stomach. J Food Sci 75:E627–E635
Kovatcheva-Datchary P, Arora T (2013) Nutrition, the gut microbiome and the metabolic syndrome. Best Pract Res Clin Gastroentrol 27:59–72
Kowalczyk B, Lagzi I, Grzybowski BA (2011) Nanoseparations: strategies for size and/or shape-selective purification of nanoparticles. Curr Opin Colloid Interface Sci 16:135–148
Krug SM, Amasheh M, Dittmann I, Christoffel I, Fromm M, Amasheh S (2013) Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells. Biomaterials 34:275–282
Lai DY (2012) Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. WIREs Nanomed Nanobiotechnol 4:1–15
Lai SK, Wang Y-Y, Hanes J (2009) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Del Rev 61:158–171
Lakshmanan A, Latha P, Subramanian KS (2012) Nanotoxicity—an overview. Int J Adv Life Sci 5:1–11
Lee J, Ko S, Kim H, Kwon H (2011) Integrity and cell-monolayer permeability of chitosan nanoparticles in simulated gastrointestinal fluids. Food Sci Biotechnol 20:1033–1042
Leonard F, Ali H, Collnot E-M, Crielaard BJ, Lammers T, Storm G, Lehr C-M (2012) Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model. Altex 29:275–285
Li Y, McClements DJ (2014) Modulating lipid droplet intestinal lipolysis by electrostatic complexation with anionic polysaccharides: influence of cosurfactants. Food Hydrocoll 35:367–374
Li Y, Hu M, Xiao H, Du Y, Decker EA, McClements DJ (2010) Controlling the functional performance of emulsion-based delivery systems using multi-component biopolymer coatings. Eur J Pharm Biopharm 76:38–47
Li X, Guo S, Zhu C, Zhu Q, Gan Y, Rantanen J, Rahbek UL, Hovgaard L, Yang M (2013) Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Biomaterials 34:9678–9687
Lin Y-H, Chung C-K, Chen C-T, Liang H-F, Chen S-C, Sung H-W (2005) Preparation of nanoparticles composed of chitosan/poly-γ-glutamic acid and evaluation of their permeability through Caco-2 cells. Biomacromolecules 6:1104–1112
Linsinger TPJ, Chaudhry Q, Dehalu V, Delahaut P, Dudkiewicz A, Grombe R, von der Kammer F, Larsen EH, Legros S, Loeschner K, Peters R, Ramsch R, Roebben G, Tiede K, Weigel S (2013) Validation of methods for the detection and quantification of engineered nanoparticles in food. Food Chem 138:1959–1966
Liu F, Urban MW (2010) Recent advances and challenges in designing stimuli-responsive polymers. Prog Polym Sci 35:3–23
Liu Z, Wang S, Hu M (2009) Oral absorption basics: pathways, physico-chemical and biological factors affecting absorption. In: Qiu Y, Chen Y, Zhang GGZ, Liu L, Porter WR (eds) Developing solid oral dosage forms. Academic Press, San Diego, pp 263–288
Liu Y, Wang P, Sun C, Zhao J, Du Y, Shi F, Feng N (2011) Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin. Int J Pharm 419:260–265
Loh JW, Saunders M, Lim L-Y (2012) Cytotoxicity of monodispersed chitosan nanoparticles against the Caco-2 cells. Toxicol Appl Pharmacol 262:273–282
Lopes MA, Abrahim BA, Cabral LM, Rodrigues CR, Seiça RMF, de Baptista Veiga FJ, Ribeiro AJ (2014) Intestinal absorption of insulin nanoparticles: contribution of M cells. Nanomed Nanotechnol Biol Med 10(6):1139–1151
Loretz B, Bernkop-Schnurch A (2007) In vitro cytotoxicity testing of non-thiolated and thiolated chitosan nanoparticles for oral gene delivery. Nanotoxicology 1:139–148
Lozano T, Rey M, Rojas E, Moya S, Fleddermann J, Estrela-Lopis I, Donath E, Wang B, Mao Z, Gao C, González-Fernández A (2011) Cytotoxicity effects of metal oxide nanoparticles in human tumor cell lines. J Phys: Conf Ser 304:012046
Lu F, Wu S-H, Hung Y, Mou C-Y (2009) Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5:1408–1413
Luo Y, Teng Z, Wang Q (2012) Development of zein nanoparticles coated with carboxymethyl chitosan for encapsulation and controlled release of vitamin D3. J Agric Food Chem 60:836–843
Ma J, Guan R, Shen H, Lu F, Xiao C, Liu M, Kang T (2013) Comparison of anticancer activity between lactoferrin nanoliposome and lactoferrin in Caco-2 cells in vitro. Food Chem Toxicol 59:72–77
Mahmoudi M, Meng J, Xue X, Liang XJ, Rahman M, Pfeiffer C, Hartmann R, Gil PR, Pelaz B, Parak WJ, del Pino P, Carregal-Romero S, Kanaras AG, Tamil Selvan S (2014) Interaction of stable colloidal nanoparticles with cellular membranes. Biotechnol Adv 32:679–692
Manke A, Wang L, Rojanasakul Y (2013) Mechanisms of nanoparticle-induced oxidative stress and toxicity. BioMed Res Int 2013:1–15
McClements DJ (2013) Edible lipid nanoparticles: digestion, absorption, and potential toxicity. Prog Lipid Res 52:409–423
McClements DJ, Xiao H (2012) Potential biological fate of ingested nanoemulsions: influence of particle characteristics. Food Funct 3:202–220
McClements DJ, Decker EA, Weiss J (2007) Emulsion-based delivery systems for lipophilic bioactive components. J Food Sci 72:R109–R124
Miller T, Rachel R, Besheer A, Uezguen S, Weigandt M, Goepferich A (2012) Comparative investigations on in vitro serum stability of polymeric micelle formulations. Pharm Res 29:448–459
Molino NM, Bilotkach K, Fraser DA, Ren D, Wang S-W (2012) Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules. Biomacromolecules 13:974–981
Mora-Huertas CE, Fessi H, Elaissari A (2010) Polymer-based nanocapsules for drug delivery. Int J Pharm 385:113–142
Moros M, Hernáez B, Garet E, Dias JT, Sáez B, Grazú V, González-Fernández A, Alonso C, de la Fuente JM (2012) Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake. ACS Nano 6:1565–1577
Motornov M, Roiter Y, Tokarev I, Minko S (2010) Stimuli-responsive nanoparticles, nanogels and capsules for integrated multifunctional intelligent systems. Prog Polym Sci 35:174–211
Mwilu SK, El Badawy AM, Bradham K, Nelson C, Thomas D, Scheckel KG, Tolaymat T, Ma L, Rogers KR (2013) Changes in silver nanoparticles exposed to human synthetic stomach fluid: effects of particle size and surface chemistry. Sci Total Environ 447:90–98
NanoLyse (2010) Nanoparticles in food: analytical methods for detection and characterisation. Project funded by the European Union’s framework programme. http://www.nanolyse.eu/default.aspx. Accessed 13 June 2014
Neal AL (2008) What can be inferred from bacterium–nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles? Ecotoxicology 17:362–371
Norris DA, Sinko PJ (1997) The role of surface hydrophobicity in the transport of polystyrene microspheres through Caco-2 cell monolayers and intestinal mucin. In: Proceedings of the controlled release society, pp 17–18
Ofokansi K, Winter G, Fricker G, Coester C (2010) Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery. Eur J Pharm Biopharm 76:1–9
Oh JK, Lee DI, Park JM (2009) Biopolymer-based microgels/nanogels for drug delivery applications. Prog Polym Sci 34:1261–1282
Papasani MR, Wang G, Hill RA (2012) Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. Nanomed Nanotechnol Biol Med 8:804–814
Patil S, Sandberg A, Heckert E, Self W, Seal S (2007) Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28:4600–4607
Peng Q, Zhang S, Yang Q, Zhang T, Wei X-Q, Jiang L, Zhang C-L, Chen Q-M, Zhang Z-R, Lin Y-F (2013) Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials 34:8521–8530
Pérez OE, David-Birman T, Kesselman E, Levi-Tal S, Lesmes U (2014) Milk protein–vitamin interactions: formation of beta-lactoglobulin/folic acid nano-complexes and their impact on in vitro gastro-duodenal proteolysis. Food Hydrocoll 38:40–47
Peters R, Dam G, Bouwmeester H, Helsper H, Allmaier G, Kammer F, Ramsch R, Solans C, Tomaniov M, Hajslova J, Weigel S (2011) Identification and characterization of organic nanoparticles in food. TrAC-Trend Anal Chem 30:100–112
Pinheiro AC, Lad M, Silva HD, Coimbra MA, Boland M, Vicente AA (2013) Unravelling the behaviour of curcumin nanoemulsions during in vitro digestion: effect of the surface charge. Soft Matter 9:3147
Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F (2006) Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed Nanotechnol Biol Med 2:8–21
Plapied L, Duhem N, des Rieux A, Préat V (2011) Fate of polymeric nanocarriers for oral drug delivery. Curr Opin Colloid Interface Sci 16:228–237
Poma A, Di Giorgio ML (2008) Toxicogenomics to improve comprehension of the mechanisms underlying responses of in vitro and in vivo systems to nanomaterials: a review. Curr Genomics 9:571–585
M-M P, Somchue W, Shiowatana J, Siripinyanond A (2014) Flow field-flow fractionation for particle size characterization of selenium nanoparticles incubated in gastrointestinal conditions. Food Res Int 57:203–209
Powell JJ, Faria N, Thomas-McKay E, Pele LC (2010) Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 34:J226–J233
Prego C, Paolicelli P, Díaz B, Vicente S, Sánchez A, González-Fernández Á, Alonso MJ (2010) Chitosan-based nanoparticles for improving immunization against hepatitis B infection. Vaccine 28:2607–2614
Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P (1993) Development of a new drug carrier made from alginate. J Pharm Sci 82:912–917
Rao JP, Geckeler KE (2011) Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci 36:887–913
Roger E, Kalscheuer S, Kirtane A, Guru BR, Grill AE, Whittum-Hudson J, Panyam J (2012) Folic acid functionalized nanoparticles for enhanced oral drug delivery. Mol Pharm 9:2103–2110
Rosenblum D, Peer D (2014) Omics-based nanomedicine: the future of personalized oncology. Cancer Lett 352:126–136
Rubinstein M, Colby RH (2003) Polymer physics. Oxford University Press, Oxford
Ruh H, Kühl B, Brenner-Weiss G, Hopf C, Diabaté S, Weiss C (2012) Identification of serum proteins bound to industrial nanomaterials. Toxicol Lett 208:41–50
Sagalowicz L, Leser ME (2010) Delivery systems for liquid food products. Curr Opin Colloid Interface Sci 15:61–72
Sahay G, Alakhova DY, Kabanov AV (2010) Endocytosis of nanomedicines. J Control Release 145:182–195
Salminen H, Weiss J (2014) Electrostatic adsorption and stability of whey protein–pectin complexes on emulsion interfaces. Food Hydrocoll 35:410–419
Salvia-Trujillo L, Qian C, Martín-Belloso O, McClements DJ (2013) Influence of particle size on lipid digestion and β-carotene bioaccessibility in emulsions and nanoemulsions. Food Chem 141:1472–1480
Sanguansri P, Augustin MA (2006) Nanoscale materials development—a food industry perspective. Trends Food Sci Technol 17:547–556
Sarmento B, das Neves J (2012) Chitosan-based systems for biopharmaceuticals: delivery, targeting and polymer therapeutics. Wiley, Chichester
Semete B, Booysen LIJ, Kalombo L, Venter JD, Katata L, Ramalapa B, Verschoor JÁ, Swai H (2010) In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles. Toxicol Appl Pharmacol 249:158–165
Sessa M, Balestrieri ML, Ferrari G, Servillo L, Castaldo D, D’Onofrio N, Donsì F, Tsao R (2014) Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems. Food Chem 147:42–50
Sharifi S, Behzadi S, Laurent S, Laird Forrest M, Stroeve P, Mahmoudi M (2012) Toxicity of nanomaterials. Chem Soc Rev 41:2323
Sheng Y, He H, Zou H (2014) Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase. Drug Deliv 21:370–378
Shpigelman A, Cohen Y, Livney YD (2012) Thermally-induced β-lactoglobulin–EGCG nanovehicles: loading, stability, sensory and digestive-release study. Food Hydrocoll 29:57–67
Silva HD, Cerqueira MA, Vicente AA (2011) Nanoemulsions for food applications: development and characterization. Food Bioprocess Technol 5:854–867
Simón-Vázquez R, Lozano-Fernández T, Peleteiro-Olmedo M, González-Fernández Á (2014) Conformational changes in human plasma proteins induced by metal oxide nanoparticles. Colloids Surf B Biointerfaces 113:198–206
Sneharani AH, Karakkat JV, Singh SA, Rao AGA (2010) Interaction of curcumin with β-lactoglobulin—stability, spectroscopic analysis, and molecular modeling of the complex. J Agric Food Chem 58:11130–11139
Somchue W, Sermsri W, Shiowatana J, Siripinyanond A (2009) Encapsulation of α-tocopherol in protein-based delivery particles. Food Res Int 42:909–914
Sonaje K, Lin Y-H, Juang J-H, Wey S-P, Chen C-T, Sung H-W (2009) In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30:2329–2339
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70:1–20
Subirade M, Chen L (2008) In: Garti N (ed) Delivery and controlled release of bioactives in foods and nutraceuticals, 1st edn. CRC Press, Cambridge
Sukhorukov GB, Donath E, Davis S, Lichtenfeld H, Caruso F, Popov VI, MoÈhwald H (1998) Stepwise polyelectrolyte assembly on particle surfaces: a novel approach to colloid design. Polym Advan Technol 9:759–767
Szakal C, Roberts SM, Westerhoff P, Bartholomaeus A, Buck N, Illuminato I, Canady R, Rogers M (2014) Measurement of nanomaterials in foods: integrative consideration of challenges and future prospects. ACS Nano 8:3128–3135
Tan JPK, Wang Q, Tam KC (2008) Control of burst release from nanogels via layer by layer assembly. J Control Release 128:248–254
Tang D-W, Yu S-H, Ho Y-C, Huang B-Q, Tsai G-J, Hsieh H-Y, Sung H-W, Mi F-L (2013) Characterization of tea catechins-loaded nanoparticles prepared from chitosan and an edible polypeptide. Food Hydrocoll 30:33–41
Tatiraju DV, Bagade VB, Karambelkar PJ, Jadhav VM, Kadam V (2013) Natural bioenhancers: an overview. J Pharmacogn Phytochem 2:55–60
Teng Z, Li Y, Luo Y, Zhang B, Wang Q (2013) Cationic β-lactoglobulin nanoparticles as a bioavailability enhancer: protein characterization and particle formation. Biomacromolecules 14:2848–2856
Teng Z, Luo Y, Wang T, Zhang B, Wang Q (2013) Development and application of nanoparticles synthesized with folic acid conjugated soy protein. J Agric Food Chem 61:2556–2564
Thanki K, Gangwal RP, Sangamwar AT, Jain S (2013) Oral delivery of anticancer drugs: challenges and opportunities. J Control Release 170:15–40
Ting Y, Jiang Y, Ho C-T, Huang Q (2014) Common delivery systems for enhancing in vivo bioavailability and biological efficacy of nutraceuticals. J Funct Foods 7:112–128
Torne SJ, Ansari KA, Vavia PR, Trotta F, Cavalli R (2010) Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges. Drug Deliv 17:419–425
Torres-Lugo M, García M, Record R, Peppas NA (2002) pH-sensitive hydrogels as gastrointestinal tract absorption enhancers: transport mechanisms of salmon calcitonin and other model molecules using the Caco-2 cell model. Biotechnol Prog 18:612–616
Totosaus A, Montejano JG, Salazar JA, Guerrero I (2002) A review of physical and chemical protein-gel induction. Int J Food Sci Technol 37:589–601
Troncoso E, Aguilera JM, McClements DJ (2012) Influence of particle size on the in vitro digestibility of protein-coated lipid nanoparticles. J Colloid Interface Sci 382:110–116
Vander AJ, Sherman J, Luciano DS (eds) (2011) The digestion and absorption of food. Human physiology: the mechanism of body function, 8th edn. The McGraw-Hill Companies, New York, pp 553–591
Vega-Villa KR, Takemoto JK, Yáñez JA, Remsberg CM, Forrest ML, Davies NM (2008) Clinical toxicities of nanocarrier systems. Adv Drug Del Rev 60:929–938
Vicente S, Diaz-Freitas B, Peleteiro M, Sanchez A, Pascual DW, Gonzalez-Fernandez A, Alonso MJ (2013) A polymer/oil based nanovaccine as a single-dose immunization approach. PLoS ONE 8(e62500):1–8
Vinogradov SV, Bronich TK, Kabanov AV (2002) Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Del Rev 54:135–147
Wang R, Tian Z, Chen L (2011) Nano-encapsulations liberated from barley protein microparticles for oral delivery of bioactive compounds. Int J Pharm 406:153–162
Wang F, Yu L, Monopoli MP, Sandin P, Mahon E, Salvati A, Dawson KA (2013) The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomed Nanotechnol Biol Med 9:1159–1168
Wang Y, Ma Y, Zheng Y, Song J, Yang X, Bi C, Zhang D, Zhang Q (2013) In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. Int J Pharm 441:728–735
Woitiski CB, Sarmento B, Carvalho RA, Neufeld RJ, Veiga F (2011) Facilitated nanoscale delivery of insulin across intestinal membrane models. Int J Pharm 412:123–131
Wolfram J, Yang Y, Shen J, Moten A, Chen C, Shen H, Ferrari M, Zhao Y (2014) The nano-plasma interface: implications of the protein corona. Colloids Surf B Biointerfaces 124:17–24
Wong JE, Müller CB, Díez-Pascual AM, Richtering W (2009) Study of layer-by-layer films on thermoresponsive nanogels using temperature-controlled dual-focus fluorescence correlation spectroscopy. J Phys Chem B 113:15907–15913
Xu S, Olenyuk BZ, Okamoto CT, Hamm-Alvarez SF (2013) Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv Drug Del Rev 65:121–138
Yan L, Gu Z, Zhao Y (2013) Chemical mechanisms of the toxicological properties of nanomaterials: generation of intracellular reactive oxygen species. Chem Asian J 8:2342–2353
Yin Y, Chen D, Qiao M, Lu Z, Hu H (2006) Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. J Control Release 116:337–345
Zattoni A, Roda B, Borghi F, Marassi V, Reschiglian P (2014) Flow field-flow fractionation for the analysis of nanoparticles used in drug delivery. J Pharm Biomed Anal 87:53–61
Zhang Z-H, Wang X-P, Ayman WY, Munyendo WL, Lv H-X, Zhou J-P (2013) Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Drug Deliv 20:86–93
Zhang H, Mi J, Huo Y, Huang X, Xing J, Yamamoto A, Gao Y (2014) Absorption enhancing effects of chitosan oligomers on the intestinal absorption of low molecular weight heparin in rats. Int J Pharm 466:156–162
Zhang X, Qi J, Lu Y, He W, Li X, Wu W (2014) Biotinylated liposomes as potential carriers for the oral delivery of insulin. Nanomed Nanotechnol Biol Med 10:167–176
Zhao J, Castranova V (2011) Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B 14:593–632
Zhaojie M, Ming Z, Shengnan W, Xiaojia B, Hatch GM, Jingkai G, Li C (2014) Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability. Int J Pharm 467:50–59
Zhu C, Gupta A, Hall VL, Rayla AL, Christensen RG, Dake B, Lakshmanan A, Kuperwasser C, Stormo GD, Wolfe SA (2013) Using defined finger–finger interfaces as units of assembly for constructing zinc-finger nucleases. Nucleic Acids Res 41:2455–2465
Zimet P, Livney YD (2009) Beta-lactoglobulin and its nanocomplexes with pectin as vehicles for ω-3 polyunsaturated fatty acids. Food Hydrocoll 23:1120–1126
Zolnik BS, González-Fernández Á, Sadrieh N, Dobrovolskaia MA (2010) Minireview: nanoparticles and the immune system. Endocrinology 151:458–465
Acknowledgments
Joana T. Martins, Óscar L. Ramos, Ana C. Pinheiro, Ana I. Bourbon, Hélder D. Silva and Miguel A. Cerqueira (SFRH/BPD/89992/2012, SFRH/BPD/80766/2011, SFRH/BPD/101181/2014, SFRH/BD/73178/2010, SFRH/BD/81288/2011, and SFRH/BPD/72753/2010, respectively) are the recipients of a fellowship from the Fundação para a Ciência e Tecnologia (FCT, POPH-QREN and FSE, Portugal). The authors thank the FCT Strategic Project PEst-OE/EQB/LA0023/2013 and the project “BioInd–Biotechnology and Bioengineering for improved Industrial and Agro-Food processes,” REF.NORTE-07-0124-FEDER-000028, co-funded by the Programa Operacional Regional do Norte (ON.2—O Novo Norte), QREN, FEDER. We also thank to the European Commission: BIOCAPS (316265, FP7/REGPOT-2012-2013.1) and Xunta de Galicia: Agrupamento INBIOMED (2012/273) and Grupo con potencial de crecimiento. The support of EU Cost Action FA1001 is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martins, J.T., Ramos, Ó.L., Pinheiro, A.C. et al. Edible Bio-Based Nanostructures: Delivery, Absorption and Potential Toxicity. Food Eng Rev 7, 491–513 (2015). https://doi.org/10.1007/s12393-015-9116-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12393-015-9116-0